Quantum Biopharma licensee Unbuzzd to host webinar

Executive Summary

• Quantum Biopharma Ltd.'s licensee, Unbuzzd Wellness Inc., is hosting a live investor webinar and Q&A session on October 1, 2025, to discuss its Regulation D 506(c) offering.
• The offering aims to raise up to $5 million (U.S.) to support direct-to-consumer, distributor, and retail expansion plans, with the ultimate goal of establishing a path to a possible initial public offering.
• Quantum Biopharma shareholders will not be diluted by this specific offering; Quantum retains a 20.10% ownership stake in Unbuzzd Wellness and is entitled to a 7% royalty on sales until $250 million is reached, after which it drops to 3% in perpetuity.

Key Details

• Webinar Details: Hosted by Unbuzzd Wellness Inc. on Wednesday, October 1, 2025, at 4:30 p.m. EST (1:30 p.m. PST).
• Offering Structure: Regulation D 506(c) offering.
• Capital Raise: Up to $5 million (U.S.).
• Use of Proceeds: Support direct-to-consumer, distributor, and retail expansion plans; establish a path to a possible initial public offering.
• Shareholder Impact: Quantum Biopharma shareholders will not be diluted by this offering.
• Ownership Stake: Quantum Biopharma retains 20.10% ownership of Unbuzzd Wellness Inc. (as of June 30, 2025).
• Royalty Agreement: Quantum Biopharma receives 7% of sales from Unbuzzd until cumulative payments reach $250 million. Thereafter, the royalty rate drops to 3% in perpetuity.
• IP Rights: Quantum Biopharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.
• Key Speakers: John Duffy (CEO, Unbuzzd), Jason Sawyer (Adviser), Dr. Eric Hoskins (Medical Director), and Gerry David (Board Co-Chair).

Notable Quotes

• "We look forward to hosting potential investors for a discussion about how Unbuzzd is changing the way the world recovers from alcohol with our clinically proven wellness and recovery consumer product. We'll also discuss the compelling opportunity for investors to be part of our success through our Regulation D 506(c) offering to raise up to $5.0-million (U.S.) to support direct-to-consumer, distributor and retail expansion plans, and establish a path to a possible initial public offering." — John Duffy, CEO, Unbuzzd Wellness Inc.